Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients

March 9, 2022 updated by: ARGUISUELAS MARTINEZ MARÍA DOLORES, Cardenal Herrera University
The purpose of this study is to analyse the effects of neuromuscular training on functional capacity in patients with acute coronary syndrome, compared to the classic strength training of the cardiac rehabilitation programs

Study Overview

Detailed Description

So far, there are no previous studies that analyze the effects of neuromuscular training on functional capacity in patients with acute coronary syndrome.

Aim: The main objective of this study is to assess the effects of a 10 weeks neuromuscular training vs traditional strength training programme in patients with acute coronary syndrome.

Design: Randomized clinical trial

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain
        • Arguisuelas Martinez Maria Dolores

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Acute coronary syndrome patients
  • Physical activity must have been prescribed

Exclusion Criteria:

  • inflammatory cardiac disease
  • severe or moderate ventricular dysfunction
  • heart failure
  • severe arrhytmias
  • systemic hypertension >95% percentile
  • pulmonary hypertension >40 mmHg
  • aortic stenosis
  • baseline O2 <90%
  • severe valve insufficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuromuscular training group
This group will receive a 60-min neuromuscular training sessions twice a week, for 10 weeks until the completion of twenty sessions
The exercise training was developed based on assuring the correct performance of the exercise focusing in motor control.
Active Comparator: Conventional training group
This group will receive a 60-min convencional cardiac rehabiliation session twice a week, for 10 weeks until the completion of twenty sessions
The exercise training was developed based on standard strength training used in cardiac rehabiliation programmes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incremental Shuttle Walking Test
Time Frame: 10 weeks
Maximum distance reached
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chester Step Test
Time Frame: 10 weeks
Time performing the test
10 weeks
30 seconds sit-to- stand test
Time Frame: 10 weeks
Number of repetitions
10 weeks
Changes in hip muscle strength
Time Frame: 10 weeks
Measured with dynamometer
10 weeks
Cardiopulmonary exercise testing
Time Frame: 10 weeks
METS achieved in ergometry
10 weeks
Sexual Health Inventory for Men
Time Frame: 10 weeks
questionnaire score
10 weeks
EQ-5D-5L
Time Frame: 10 weeks
Health Related Quality of Life measure
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Dolores Arguisuelas, Cardenal Herrera University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

July 30, 2021

Study Completion (Actual)

January 30, 2022

Study Registration Dates

First Submitted

January 27, 2020

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 29, 2020

Study Record Updates

Last Update Posted (Actual)

March 10, 2022

Last Update Submitted That Met QC Criteria

March 9, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Neuromuscular training

Subscribe